Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2022 09:16 ET | Source: Coloplast A/S

Coloplast A/S - Coloplast gennemfører opkøbet af Atos Medical

Coloplast har nu gennemført opkøbet af Atos Medical, der blev offentliggjort den 8. november 2021, efter godkendelse fra de relevante myndigheder. Vilkårene er som angivet i Coloplasts...
January 31, 2022 09:16 ET | Source: Coloplast A/S

Coloplast A/S - Coloplast completes the acquisition of Atos Medical

Coloplast has now completed the acquisition of Atos Medical announced on November 8, 2021 after receiving approval from relevant authorities. All terms remain as stated in Coloplast's stock...
January 26, 2022 09:55 ET | Source: Coloplast A/S

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier

Se venligst vedlagte pdf. Vedhæftet fil 26012022_handel_med_aktier_MW ...
January 26, 2022 09:55 ET | Source: Coloplast A/S

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Please see enclosed pdf. Attachment 26012022_trading_in_shares_MW ...
January 25, 2022 07:08 ET | Source: Coloplast A/S

Coloplast A/S - Allokering af aktieoptioner

Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer I henhold til Markedsmisbrugsforordningen art. 19 skal Coloplast...
January 25, 2022 07:08 ET | Source: Coloplast A/S

Coloplast A/S - Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the...
January 25, 2022 06:10 ET | Source: Coloplast A/S

Coloplast leverer en solid start på året med 6% organisk vækst i 1. kvartal og en overskudsgrad før særlige poster på 32%

De finansielle forventninger for 2021/22 opdateres som følge af opkøbet af Atos Medical, der forventes afsluttet 31. januar 2022. Forventningen til den organiske omsætningsvækst er uændret,...
January 25, 2022 06:10 ET | Source: Coloplast A/S

Coloplast delivers solid start to the year with 6% organic growth in Q1 and a 32% EBIT margin before special items

The company is updating its financial guidance for 2021/22 to reflect the Atos Medical acquisition, which is targeted to close on January 31, 2022. Organic revenue growth guidance is unchanged,...
January 25, 2022 06:06 ET | Source: Coloplast A/S

Coloplast A/S - Selskabsmeddelelse nr. 01/2022 - Regnskabsmeddelelse, Q1 2021/22

Q1 2021/22 Regnskabsmeddelelse, 1. kvartal 2021/221. oktober 2021 – 31. december 2021 Coloplast leverer en solid start på året med 6% organisk vækst og en overskudsgrad før særlige poster på 32%....
January 25, 2022 06:06 ET | Source: Coloplast A/S

Coloplast A/S - Announcement no. 01/2022 – Interim Financial Report, Q1 2021/22

Q1 2021/22Interim financial results, Q1 2021/221 October 2021 - 31 December 2021 Coloplast delivers a solid Q1 with 6% organic growth and 32% EBIT margin before special items. Organic growth...